Prophylaxis and Therapy Against Chemical Agents (Prophylaxie Et Thérapie Contre Les Agents Chimiques)

Total Page:16

File Type:pdf, Size:1020Kb

Prophylaxis and Therapy Against Chemical Agents (Prophylaxie Et Thérapie Contre Les Agents Chimiques) NORTH ATLANTIC TREATY RESEARCH AND TECHNOLOGY ORGANISATION ORGANISATION AC/323(HFM-041)TP/280 www.rto.nato.int RTO TECHNICAL REPORT TR-HFM-041 Prophylaxis and Therapy Against Chemical Agents (Prophylaxie et thérapie contre les agents chimiques) Final Report of the HFM-041/TG-004 for the Period 1999 to 2005. Published November 2009 Distribution and Availability on Back Cover NORTH ATLANTIC TREATY RESEARCH AND TECHNOLOGY ORGANISATION ORGANISATION AC/323(HFM-041)TP/280 www.rto.nato.int RTO TECHNICAL REPORT TR-HFM-041 Prophylaxis and Therapy Against Chemical Agents (Prophylaxie et thérapie contre les agents chimiques) Final Report of the HFM-041/TG-004 for the Period 1999 to 2005. The final report of the HFM-041 includes the complete scientific proceedings of meetings sponsored under this task group and held in 1999, 2000, 2002, 2003 and 2005. The report also includes a summary report on bioscavengers as a new pre-treatment for nerve agent poisoning. The Research and Technology Organisation (RTO) of NATO RTO is the single focus in NATO for Defence Research and Technology activities. Its mission is to conduct and promote co-operative research and information exchange. The objective is to support the development and effective use of national defence research and technology and to meet the military needs of the Alliance, to maintain a technological lead, and to provide advice to NATO and national decision makers. The RTO performs its mission with the support of an extensive network of national experts. It also ensures effective co-ordination with other NATO bodies involved in R&T activities. RTO reports both to the Military Committee of NATO and to the Conference of National Armament Directors. It comprises a Research and Technology Board (RTB) as the highest level of national representation and the Research and Technology Agency (RTA), a dedicated staff with its headquarters in Neuilly, near Paris, France. In order to facilitate contacts with the military users and other NATO activities, a small part of the RTA staff is located in NATO Headquarters in Brussels. The Brussels staff also co-ordinates RTO’s co-operation with nations in Middle and Eastern Europe, to which RTO attaches particular importance especially as working together in the field of research is one of the more promising areas of co-operation. The total spectrum of R&T activities is covered by the following 7 bodies: • AVT Applied Vehicle Technology Panel • HFM Human Factors and Medicine Panel • IST Information Systems Technology Panel • NMSG NATO Modelling and Simulation Group • SAS System Analysis and Studies Panel • SCI Systems Concepts and Integration Panel • SET Sensors and Electronics Technology Panel These bodies are made up of national representatives as well as generally recognised ‘world class’ scientists. They also provide a communication link to military users and other NATO bodies. RTO’s scientific and technological work is carried out by Technical Teams, created for specific activities and with a specific duration. Such Technical Teams can organise workshops, symposia, field trials, lecture series and training courses. An important function of these Technical Teams is to ensure the continuity of the expert networks. RTO builds upon earlier co-operation in defence research and technology as set-up under the Advisory Group for Aerospace Research and Development (AGARD) and the Defence Research Group (DRG). AGARD and the DRG share common roots in that they were both established at the initiative of Dr Theodore von Kármán, a leading aerospace scientist, who early on recognised the importance of scientific support for the Allied Armed Forces. RTO is capitalising on these common roots in order to provide the Alliance and the NATO nations with a strong scientific and technological basis that will guarantee a solid base for the future. The content of this publication has been reproduced directly from material supplied by RTO or the authors. Published November 2009 Copyright © RTO/NATO 2009 All Rights Reserved ISBN 978-92-837-0092-0 Single copies of this publication or of a part of it may be made for individual use only. The approval of the RTA Information Management Systems Branch is required for more than one copy to be made or an extract included in another publication. Requests to do so should be sent to the address on the back cover. ii RTO-TR-HFM-041 Table of Contents Page List of Figures/Tables v Membership of Task Group – Prophylaxis and Therapy Against Chemical Agents vi HFM-041/TG-004 Executive Summary and Synthèse ES-1 Chapter 1 – Summary of the Meeting held in Brussels (BEL) 22-26 March 1999 1-1 1.1 Cooperation 1-2 Chapter 2 – Summary of the Meeting held in The Hague (NLD) 1-5 October 2000 2-1 2.1 Cooperation 2-2 Chapter 3 – Summary of the Meeting held in Oslo (NOR) 4-7 November 2002 3-1 3.1 Cooperation 3-1 Chapter 4 – Summary of the Meeting held in Medicine Hat (CAN) 29 September – 4-1 3 October 2003 4.1 Cooperation 4-2 Chapter 5 – Summary of the Meeting held in Hradec Králové (CZE) 23-26 May 5-1 2005 5.1 Cooperation 5-2 Chapter 6 – Summary of Accomplishments 6-1 Chapter 7 – Terms of Reference 7-1 Annex A – Task Group on Prophylaxis and Therapy Against Chemical Agents A-1 A.1 Meeting of TG-004 – 22-26 March 1999, Brussels, Belgium A-1 A.1.1 Program A-1 A.2 Meeting of TG-004 – 1-5 October 2000, The Hague, Netherlands A-7 A.2.1 Program A-7 A.3 Meeting of TG-004 – 4-7 November 2002, Oslo, Norway A-11 A.3.1 Program A-11 A.3.2 Posters A-17 RTO-TR-HFM-041 iii A.4 Meeting of TG-004 – 29 September – 3 October 2003, Medicine Hat, Alberta, Canada A-19 A.4.1 Program A-19 A.4.2 Posters A-21 A.5 Meeting of TG-004 – 23-26 May 2005, Hradec Králové, Czech Republic A-24 A.5.1 Program A-24 A.5.2 Posters A-29 Annex B – Nerve Agent Bioscavengers: Progress in Development of a New Mode B-1 of Protection Against Organophosphorus Exposure Abstract B-1 B.1 Introduction B-2 B.2 Current Therapy for Nerve Agent Exposure B-2 B.3 Nerve Agent Bioscavengers: An Alternative to Conventional Approaches B-3 B.4 Stoichiometric Scavengers and the Protection they Offer B-5 B.4.1 Antibodies B-5 B.4.2 Enzymes B-6 B.5 Catalytic Bioscavengers B-11 B.6 Behavioral Effects B-17 B.7 Behavioral Effects of Scavengers Alone B-17 B.8 Summary B-19 B.9 References B-20 Annex C – Complete Scientific Programs for the TG-004 Meetings held from C-1 1999 – 2005 iv RTO-TR-HFM-041 List of Figures/Tables Figure Page Figure B-1 Biochemical Basis for CaE Cellular Trafficking B-9 Figure B-2 Effect of Plasma CaE Concentration on Soman LD50 (administered subcutaneously) B-9 in Different Species Figure B-3 Comparative Reactivation Kinetics of Soman-Inhibited Human B-14 Butyrylcholinesterase Single Mutant G117H (ϒ) and Double Mutant G117H/E197Q (●) Figure B-4 A Ball and Stick Computer Model of the Active Site of the Double Mutant of B-15 Butyrylcholinesterase G117H/E197Q Table Table B-1 Protection from Organophosphorus Intoxication by Antibody Bioscavengers B-5 Table B-2 Protection from Organophosphorus Intoxication by the Bioscavenger FBS-AChE B-6 Table B-3 Protection from Organophosphorus Intoxication by the Bioscavenger eq-BuChE B-7 Table B-4 Protection from Organophosphorus Intoxication by Endogenous Plasma CaE B-8 Table B-5 Protection from Organophosphorus Intoxication by HuBuChE Bioscavengers B-11 Table B-6 Kinetic Properties of Naturally Occurring Catalytic Bioscavengers B-12 Table B-7 Kinetic Properties of Catalytic Mutated BuChE Bioscavengers B-16 Table B-8 Kinetic Properties of Mouse Derived Catalytic Antibody Bioscavengers B-17 Table B-9 Extent of Behavioral Deficits Following Bioscavenger Administration or B-18 Conventional Therapy RTO-TR-HFM-041 v Membership of Task Group – Prophylaxis and Therapy Against Chemical Agents HFM-041/TG-004 CHAIRMAN Dr. David LENZ Research Division US Army Medical Research Institute of Chemical Defense 3100 Ricketts Point Rd. Aberdeen Proving Ground, MD 21010-5400 UNITED STATES† e-mail: [email protected] CANADA NETHERLANDS Dr. Thomas SAWYER Dr. Herman VAN HELDEN DRDC Suffield Pulmonary and CNS Pharmacology Chemical Biological Defence Section TNO Defence, Security and Safety PO Box 4000 Research Group Diagnosis and Therapy Medicine Hat, Alberta T1A 8K6 PO Box 45 e-mail: [email protected] 2280 AA Rijswijk e-mail: [email protected] CZECH REPUBLIC Dr. Josef FUSEK NORWAY Vice Dean for Research, University of Defence Prof. Dr. Pål AAS Faculty of Military Health Sciences Norwegian Defence Research Establishment Department of Toxicology Division for Protection and Materiel Trebesska 1575 Postbox 25 – Instituttveien 20 500 01 Hradec Kralove NO-2027 Kjeller e-mail: [email protected] e-mail: [email protected] FRANCE* SWEDEN Dr. Patrick MASSON Dr. Gudrun CASSEL Service de Santé des Armées FOI CBRN Defence and Security 24 Avenue des Maquis du Grésivaudan Cementvägen 20 BP 87 S-90182 Umeå 38702 La Tronche Cedex e-mail: [email protected] e-mail: [email protected] UNITED KINGDOM * GERMANY Dr. Paul RICE Dr. Ladislaus SZINIZC Dstl Porton Down Institute of Pharmacology and Toxicology Salisbury, Wiltshire SP4 0JQ German Armed Forces Medical Academy e-mail: [email protected] Neuherbergstrasse 11 80937 Munich e-mail: [email protected] vi RTO-TR-HFM-041 *Current Points of Contact FRANCE GERMANY Dr. Fredric DORANDEU Dr. Horst THIERMANN Institut de Recherche Biomédicale des Armées Institute of Pharmacology and Toxicology 24 avenue des Maquis du Grésivaudan German Armed Forces Medical Academy 38702 La Tronche Cedex Neuherbergstrasse 11 e-mail: [email protected] 80937 Munich e-mail: [email protected] †Alternate Point of Contact UNITED STATES Dr.
Recommended publications
  • Rapid and Simultaneous Detection of Ricin, Staphylococcal Enterotoxin B
    Analyst PAPER View Article Online View Journal | View Issue Rapid and simultaneous detection of ricin, staphylococcal enterotoxin B and saxitoxin by Cite this: Analyst,2014,139, 5885 chemiluminescence-based microarray immunoassay† a a b b c c A. Szkola, E. M. Linares, S. Worbs, B. G. Dorner, R. Dietrich, E. Martlbauer,¨ R. Niessnera and M. Seidel*a Simultaneous detection of small and large molecules on microarray immunoassays is a challenge that limits some applications in multiplex analysis. This is the case for biosecurity, where fast, cheap and reliable simultaneous detection of proteotoxins and small toxins is needed. Two highly relevant proteotoxins, ricin (60 kDa) and bacterial toxin staphylococcal enterotoxin B (SEB, 30 kDa) and the small phycotoxin saxitoxin (STX, 0.3 kDa) are potential biological warfare agents and require an analytical tool for simultaneous detection. Proteotoxins are successfully detected by sandwich immunoassays, whereas Creative Commons Attribution-NonCommercial 3.0 Unported Licence. competitive immunoassays are more suitable for small toxins (<1 kDa). Based on this need, this work provides a novel and efficient solution based on anti-idiotypic antibodies for small molecules to combine both assay principles on one microarray. The biotoxin measurements are performed on a flow-through chemiluminescence microarray platform MCR3 in 18 minutes. The chemiluminescence signal was Received 18th February 2014 amplified by using a poly-horseradish peroxidase complex (polyHRP), resulting in low detection limits: Accepted 3rd September 2014 2.9 Æ 3.1 mgLÀ1 for ricin, 0.1 Æ 0.1 mgLÀ1 for SEB and 2.3 Æ 1.7 mgLÀ1 for STX. The developed multiplex DOI: 10.1039/c4an00345d system for the three biotoxins is completely novel, relevant in the context of biosecurity and establishes www.rsc.org/analyst the basis for research on anti-idiotypic antibodies for microarray immunoassays.
    [Show full text]
  • Biological Toxins Fact Sheet
    Work with FACT SHEET Biological Toxins The University of Utah Institutional Biosafety Committee (IBC) reviews registrations for work with, possession of, use of, and transfer of acute biological toxins (mammalian LD50 <100 µg/kg body weight) or toxins that fall under the Federal Select Agent Guidelines, as well as the organisms, both natural and recombinant, which produce these toxins Toxins Requiring IBC Registration Laboratory Practices Guidelines for working with biological toxins can be found The following toxins require registration with the IBC. The list in Appendix I of the Biosafety in Microbiological and is not comprehensive. Any toxin with an LD50 greater than 100 µg/kg body weight, or on the select agent list requires Biomedical Laboratories registration. Principal investigators should confirm whether or (http://www.cdc.gov/biosafety/publications/bmbl5/i not the toxins they propose to work with require IBC ndex.htm). These are summarized below. registration by contacting the OEHS Biosafety Officer at [email protected] or 801-581-6590. Routine operations with dilute toxin solutions are Abrin conducted using Biosafety Level 2 (BSL2) practices and Aflatoxin these must be detailed in the IBC protocol and will be Bacillus anthracis edema factor verified during the inspection by OEHS staff prior to IBC Bacillus anthracis lethal toxin Botulinum neurotoxins approval. BSL2 Inspection checklists can be found here Brevetoxin (http://oehs.utah.edu/research-safety/biosafety/ Cholera toxin biosafety-laboratory-audits). All personnel working with Clostridium difficile toxin biological toxins or accessing a toxin laboratory must be Clostridium perfringens toxins Conotoxins trained in the theory and practice of the toxins to be used, Dendrotoxin (DTX) with special emphasis on the nature of the hazards Diacetoxyscirpenol (DAS) associated with laboratory operations and should be Diphtheria toxin familiar with the signs and symptoms of toxin exposure.
    [Show full text]
  • Biological Toxins As the Potential Tools for Bioterrorism
    International Journal of Molecular Sciences Review Biological Toxins as the Potential Tools for Bioterrorism Edyta Janik 1, Michal Ceremuga 2, Joanna Saluk-Bijak 1 and Michal Bijak 1,* 1 Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland; [email protected] (E.J.); [email protected] (J.S.-B.) 2 CBRN Reconnaissance and Decontamination Department, Military Institute of Chemistry and Radiometry, Antoniego Chrusciela “Montera” 105, 00-910 Warsaw, Poland; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +48-(0)426354336 Received: 3 February 2019; Accepted: 3 March 2019; Published: 8 March 2019 Abstract: Biological toxins are a heterogeneous group produced by living organisms. One dictionary defines them as “Chemicals produced by living organisms that have toxic properties for another organism”. Toxins are very attractive to terrorists for use in acts of bioterrorism. The first reason is that many biological toxins can be obtained very easily. Simple bacterial culturing systems and extraction equipment dedicated to plant toxins are cheap and easily available, and can even be constructed at home. Many toxins affect the nervous systems of mammals by interfering with the transmission of nerve impulses, which gives them their high potential in bioterrorist attacks. Others are responsible for blockage of main cellular metabolism, causing cellular death. Moreover, most toxins act very quickly and are lethal in low doses (LD50 < 25 mg/kg), which are very often lower than chemical warfare agents. For these reasons we decided to prepare this review paper which main aim is to present the high potential of biological toxins as factors of bioterrorism describing the general characteristics, mechanisms of action and treatment of most potent biological toxins.
    [Show full text]
  • Botulinum Toxin Ricin Toxin Staph Enterotoxin B
    Botulinum Toxin Ricin Toxin Staph Enterotoxin B Source Source Source Clostridium botulinum, a large gram- Ricinus communis . seeds commonly called .Staphylococcus aureus, a gram-positive cocci positive, spore-forming, anaerobic castor beans bacillus Characteristics Characteristics .Appears as grape-like clusters on Characteristics .Toxin can be disseminated in the form of a Gram stain or as small off-white colonies .Grows anaerobically on Blood Agar and liquid, powder or mist on Blood Agar egg yolk plates .Toxin-producing and non-toxigenic strains Pathogenesis of S. aureus will appear morphologically Pathogenesis .A-chain inactivates ribosomes, identical interrupting protein synthesis .Toxin enters nerve terminals and blocks Pathogenesis release of acetylcholine, blocking .B-chain binds to carbohydrate receptors .Staphylococcus Enterotoxin B (SEB) is a neuro-transmission and resulting in on the cell surface and allows toxin superantigen. Toxin binds to human class muscle paralysis complex to enter cell II MHC molecules causing cytokine Toxicity release and system-wide inflammation Toxicity .Highly toxic by inhalation, ingestion Toxicity .Most lethal of all toxic natural substances and injection .Toxic by inhalation or ingestion .Groups A, B, E (rarely F) cause illness in .Less toxic by ingestion due to digestive humans activity and poor absorption Symptoms .Low dermal toxicity .4-10 h post-ingestion, 3-12 h post-inhalation Symptoms .Flu-like symptoms, fever, chills, .24-36 h (up to 3 d for wound botulism) Symptoms headache, myalgia .Progressive skeletal muscle weakness .18-24 h post exposure .Nausea, vomiting, and diarrhea .Symmetrical descending flaccid paralysis .Fever, cough, chest tightness, dyspnea, .Nonproductive cough, chest pain, .Can be confused with stroke, Guillain- cyanosis, gastroenteritis and necrosis; and dyspnea Barre syndrome or myasthenia gravis death in ~72 h .SEB can cause toxic shock syndrome + + + Gram stain Lipase on Ricin plant Castor beans S.
    [Show full text]
  • Chess & Bridge
    2013 Catalogue Chess & Bridge Plus Backgammon Poker and other traditional games cbcat2013_p02_contents_Layout 1 02/11/2012 09:18 Page 1 Contents CONTENTS WAYS TO ORDER Chess Section Call our Order Line 3-9 Wooden Chess Sets 10-11 Wooden Chess Boards 020 7288 1305 or 12 Chess Boxes 13 Chess Tables 020 7486 7015 14-17 Wooden Chess Combinations 9.30am-6pm Monday - Saturday 18 Miscellaneous Sets 11am - 5pm Sundays 19 Decorative & Themed Chess Sets 20-21 Travel Sets 22 Giant Chess Sets Shop online 23-25 Chess Clocks www.chess.co.uk/shop 26-28 Plastic Chess Sets & Combinations or 29 Demonstration Chess Boards www.bridgeshop.com 30-31 Stationery, Medals & Trophies 32 Chess T-Shirts 33-37 Chess DVDs Post the order form to: 38-39 Chess Software: Playing Programs 40 Chess Software: ChessBase 12` Chess & Bridge 41-43 Chess Software: Fritz Media System 44 Baker Street 44-45 Chess Software: from Chess Assistant 46 Recommendations for Junior Players London, W1U 7RT 47 Subscribe to Chess Magazine 48-49 Order Form 50 Subscribe to BRIDGE Magazine REASONS TO SHOP ONLINE 51 Recommendations for Junior Players - New items added each and every week 52-55 Chess Computers - Many more items online 56-60 Bargain Chess Books 61-66 Chess Books - Larger and alternative images for most items - Full descriptions of each item Bridge Section - Exclusive website offers on selected items 68 Bridge Tables & Cloths 69-70 Bridge Equipment - Pay securely via Debit/Credit Card or PayPal 71-72 Bridge Software: Playing Programs 73 Bridge Software: Instructional 74-77 Decorative Playing Cards 78-83 Gift Ideas & Bridge DVDs 84-86 Bargain Bridge Books 87 Recommended Bridge Books 88-89 Bridge Books by Subject 90-91 Backgammon 92 Go 93 Poker 94 Other Games 95 Website Information 96 Retail shop information page 2 TO ORDER 020 7288 1305 or 020 7486 7015 cbcat2013_p03to5_woodsets_Layout 1 02/11/2012 09:53 Page 1 Wooden Chess Sets A LITTLE MORE INFORMATION ABOUT OUR CHESS SETS..
    [Show full text]
  • Retrograde Transport of Mutant Ricin to the Endoplasmic Reticulum with Subsequent Translocation to Cytosol (Ricin͞toxin͞translocation͞retrograde Transport͞sulfation)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 3783–3788, April 1997 Cell Biology Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol (ricinytoxinytranslocationyretrograde transportysulfation) ANDRZEJ RAPAK,PÅL Ø. FALNES, AND SJUR OLSNES* Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway Communicated by R. John Collier, Harvard Medical School, Boston, MA, January 30, 1997 (received for review November 25, 1996) ABSTRACT Translocation of ricin A chain to the cytosol (20). Because this labeling takes place in the Golgi apparatus, only has been proposed to take place from the endoplasmic reticulum molecules that have already been transported retrograde to the (ER), but attempts to visualize ricin in this organelle have failed. Golgi complex will be labeled. Furthermore, because only the A Here we modified ricin A chain to contain a tyrosine sulfation chain carrying the sulfation site will be labeled, the B chain, which site alone or in combination with N-glycosylation sites. When migrates at almost the same rate as the modified A chain, will not reconstituted with ricin B chain and incubated with cells in the complicate the interpretation of the data. We here present 35 presence of Na2 SO4, the modified A chains were labeled. The evidence that sulfated ricin A chain is transported retrograde to labeling was prevented by brefeldin A and ilimaquinone, and it the ER and then translocated to the cytosol. appears to take place in the Golgi apparatus. This method allows selective labeling of ricin molecules that have already been MATERIALS AND METHODS 35 transported retrograde to this organelle.
    [Show full text]
  • The Queen's Gambit
    01-01 Cover - April 2021_Layout 1 16/03/2021 13:03 Page 1 03-03 Contents_Chess mag - 21_6_10 18/03/2021 11:45 Page 3 Chess Contents Founding Editor: B.H. Wood, OBE. M.Sc † Editorial....................................................................................................................4 Executive Editor: Malcolm Pein Malcolm Pein on the latest developments in the game Editors: Richard Palliser, Matt Read Associate Editor: John Saunders 60 Seconds with...Geert van der Velde.....................................................7 Subscriptions Manager: Paul Harrington We catch up with the Play Magnus Group’s VP of Content Chess Magazine (ISSN 0964-6221) is published by: A Tale of Two Players.........................................................................................8 Chess & Bridge Ltd, 44 Baker St, London, W1U 7RT Wesley So shone while Carlsen struggled at the Opera Euro Rapid Tel: 020 7486 7015 Anish Giri: Choker or Joker?........................................................................14 Email: [email protected], Website: www.chess.co.uk Danny Gormally discusses if the Dutch no.1 was just unlucky at Wijk Twitter: @CHESS_Magazine How Good is Your Chess?..............................................................................18 Twitter: @TelegraphChess - Malcolm Pein Daniel King also takes a look at the play of Anish Giri Twitter: @chessandbridge The Other Saga ..................................................................................................22 Subscription Rates: John Henderson very much
    [Show full text]
  • Staphylococcal Enterotoxins
    Toxins 2010, 2, 2177-2197; doi:10.3390/toxins2082177 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Staphylococcal Enterotoxins Irina V. Pinchuk 1, Ellen J. Beswick 2 and Victor E. Reyes 3,* 1 Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555-0655, USA; E-Mail: [email protected] 2 Department of Molecular Genetics & Microbiology, University of New Mexico, Albuquerque, NM 87131, USA; E-Mail: [email protected] 3 Departments of Pediatrics and Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555-0366, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-409-772-3824; Fax: +1-409-772-1761. Received: 29 June 2010; in revised form: 9 August 2010 / Accepted: 12 August 2010 / Published: 18 August 2010 Abstract: Staphylococcus aureus (S. aureus) is a Gram positive bacterium that is carried by about one third of the general population and is responsible for common and serious diseases. These diseases include food poisoning and toxic shock syndrome, which are caused by exotoxins produced by S. aureus. Of the more than 20 Staphylococcal enterotoxins, SEA and SEB are the best characterized and are also regarded as superantigens because of their ability to bind to class II MHC molecules on antigen presenting cells and stimulate large populations of T cells that share variable regions on the chain of the T cell receptor. The result of this massive T cell activation is a cytokine bolus leading to an acute toxic shock. These proteins are highly resistant to denaturation, which allows them to remain intact in contaminated food and trigger disease outbreaks.
    [Show full text]
  • 618 Subpart G—General Exemptions for New Microorganisms
    § 725.370 40 CFR Ch. I (7–1–11 Edition) the conditions of the proposed test porting of certain new microorganisms marketing activity. for commercial purposes. (e) Persons applying for a TME must (b) Recipient microorganisms eligible also submit the following information for the tiered exemption from review about the proposed test marketing ac- under this part are listed in § 725.420. tivity: (c) Criteria for the introduced ge- (1) Proposed test marketing activity. (i) netic material contained in the new The maximum quantity of the micro- microorganisms are described in organism which the applicant will § 725.421. manufacture or import for test mar- (d) Physical containment and control keting. (ii) The maximum number of persons technologies are described in § 725.422. who may be provided the microorga- (e) The conditions for the Tier I ex- nism during test marketing. emption are listed in § 725.424. (iii) The maximum number of persons (f) In lieu of complying with subpart who may be exposed to the microorga- D of this part, persons using recipient nism as a result of test marketing, in- microorganisms eligible for the tiered cluding information regarding duration exemption may submit a Tier II ex- and route of such exposures. emption request. The limited reporting (iv) A description of the test mar- requirements for the Tier II exemption, keting activity, including its duration including data requirements, are de- and how it can be distinguished from scribed in §§ 725.450 and 725.455. full-scale commercial production and (g) EPA review procedures for the research and development activities. Tier II exemption are set forth in (2) Health and environmental effects § 725.470.
    [Show full text]
  • The Analytical Thinking Process a Practical Thinking Guide for Developing Chess Players
    The Analytical Thinking Process A Practical Thinking Guide For Developing Chess Players Learn the powerful thinking methods that will help you find good moves consistently. by Louis Holtzhausen Chess is about finding good moves. To that end, The Analytical Thinking Process is based on the premise that a good move is a move that makes progress towards your objectives and/or prevents your opponent from achieving the same. The Analytical Thinking Process will introduce you to highly efficient and effective thinking methods that help you achieve your objectives by means of 3 important processes: 1. Evaluation 2. Planning (Strategy) 3. Calculation Evaluation is the process whereby you compare the progress you’ve made towards your objectives to the progress your opponent has made in the same. The evaluation process will also help you understand the need of the position and help you find plausible candidate moves. Planning is the process whereby you identify a relevant strategy based on the needs of the position. An effective planning process relies on the evaluation method to gather important information about the position. At the same time you will rely on your calculation skill to verify whether your idea is tactically safe. Calculation is the process whereby you foresee all the critical variations and tactics that exist in the current position, as well as variations that will be possible as a result of the candidate move/s you are considering. The 3 Aspects of an Effective Chess Thinking Process Evaluation >> Strategy (Planning) << Calculation Use the 5-step evaluation method to Identify a relevant strategy based Use the 5-step calculation method to evaluate the position: on the stage of the game and the check all the tactics in the position: need of the position: 1.
    [Show full text]
  • Rakhmanov's Secrets of Opening Preparation First Edition 2021 by Thinkers Publishing Copyright © 2021 Aleksandr Rakhmanov
    Rakhmanov's Secrets of Opening Preparation First edition 2021 by Thinkers Publishing Copyright © 2021 Aleksandr Rakhmanov All rights reserved. No part of this publication may be reproduced, stored in a re- trieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission from the publisher. All sales or enquiries should be directed to Thinkers Publishing, 9850 Landegem, Belgium. Email: [email protected] Website: www.thinkerspublishing.com Managing Editor: Romain Edouard Assistant Editor: Daniël Vanheirzeele Typesetting: Mark Haast Proofreading: Kai Tan Software: Hub van de Laar Cover Design: Iwan Kerkhof Graphic Artist: Philippe Tonnard Production: BESTinGraphics ISBN: 9789464201277 D/2021/13730/5 Rakhmanov's Secrets of Opening Preparation Aleksandr Rakhmanov Thinkers Publishing 2021 Key to Symbols ! a good move ? a weak move !! an excellent move ?? a blunder !? an interesting move ?! a dubious move □ only move N novelty ⟳ lead in development ⨀ zugzwang = equality ∞ unclear position © with compensation for the sacrificed material ⩲ White stands slightly better ⩱ Black stands slightly better ± White has a serious advantage ∓ Black has a serious advantage +- White has a decisive advantage -+ Black has a decisive advantage → with an attack ↑ with initiative ⇆ with counterplay ∆ with the idea of ⌓ better is ≤ worse is + check # mate Table of Contents Key to Symbols ....................................................................................................
    [Show full text]
  • A Beginner's Guide to Coaching Scholastic Chess
    A Beginner’s Guide To Coaching Scholastic Chess by Ralph E. Bowman Copyright © 2006 Foreword I started playing tournament Chess in 1962. I became an educator and began coaching Scholastic Chess in 1970. I became a tournament director and organizer in 1982. In 1987 I was appointed to the USCF Scholastic Committee and have served each year since, for seven of those years I served as chairperson or co-chairperson. With that experience I have had many beginning coaches/parents approach me with questions about coaching this wonderful game. What is contained in this book is a compilation of the answers to those questions. This book is designed with three types of persons in mind: 1) a teacher who has been asked to sponsor a Chess team, 2) parents who want to start a team at the school for their child and his/her friends, and 3) a Chess player who wants to help a local school but has no experience in either Scholastic Chess or working with schools. Much of the book is composed of handouts I have given to students and coaches over the years. I have coached over 600 Chess players who joined the team knowing only the basics. The purpose of this book is to help you to coach that type of beginning player. What is contained herein is a summary of how I run my practices and what I do with beginning players to help them enjoy Chess. This information is not intended as the one and only method of coaching. In all of my college education classes there was only one thing that I learned that I have actually been able to use in each of those years of teaching.
    [Show full text]